Drug surveillance. Establishment of a benefit/risk ratio in current practice
Demarez, J.P.; Couzinier, J.P.; Begaud, B.
Therapie 40(5): 333-335
1985
ISSN/ISBN: 0040-5957 PMID: 4095691 Document Number: 253175
Document emailed within 1 workday
Related Documents
Nyssen, A.; Legrand, V.; Scheen, A.J. 2008: Benefit-risk ratio of coronary drug-eluting stents: 2nd part: evaluation in the diabetic population Revue Medicale de Liege 63(11): 654-661Evreux, J.C. 1984: Is establishment of causality in drug surveillance reliable? Therapie 39(4): 437-438
Gomez, H.J.; Cirillo, V.J.; Smith, S.G. 1990: Enalapril: benefit-to-risk ratio in hypertensive patients Journal of Cardiovascular Pharmacology 15 Suppl. 3: S26-S29
Ecoffey, C. 1997: Locoregional anesthesia in children: benefit/risk ratio Chirurgie; Memoires de l'Academie de Chirurgie 122(1): 39-42
Dencker, S.J. 1984: The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective Journal of Clinical Psychiatry 45(5 Part 2): 22-27
Rosner, F. 1984: Risk-benefit ratio: hazardous surgery and experimental therapy Mount Sinai Journal of Medicine new York 51(1): 58-59
Avouac, B.; Maheu, E.; Sallière, D.; Charpak, Y.; Le Loet, X. 1990: Social impact of osteoarthritis. Risk/benefit--cost/effectiveness ratio of osteoarthritis treatments Revue du Rhumatisme et des Maladies Osteo-Articulaires 57(9): 37s-43s
Prasad, G.N.; Ramasamy, S.; Thomas, J.M.; Nayar, P.G.; Sankar, M.N.; Sivakadaksham, N.; Cherian, K.M. 2010: Enhanced external counterpulsation (EECP) therapy: current evidence for clinical practice and who will benefit? Indian Heart Journal 62(4): 296-302
Maugat, S.; Joly, C.; L'hériteau, F.; Beaucaire, G.; Astagneau, P. 2005: Standardized incidence ratio: a risk index for catheter-related infection surveillance in intensive care units (REACAT network) in Northern France Revue d'Epidemiologie et de Sante Publique 53 Spec no 1: 1s39-1s46
Gardner, J. 1999: Pharmacists join drug benefit debate. if Medicare offers prescription drug benefit, pharmacists want to be reimbursed Modern Healthcare 29(49): 6
Albengres, E.; Gauthier, F.; Tillement, J.P. 1990: Current French system of post-marketing drug surveillance International Journal of Clinical Pharmacology Therapy and Toxicology 28(7): 312-314
Watt, M. 1975: Drug surveillance in general practice: a study of oxprenolol in the treatment of angina New Zealand Medical Journal 81(534): 200-202
Hedt, B.L.; Laufer, M.K.; Cohen, T. 2011: Drug resistance surveillance in resource-poor settings: current methods and considerations for TB, HIV, and malaria American Journal of Tropical Medicine and Hygiene 84(2): 192-199
Ell, C.; Domschke, S.; Domschke, W. 1982: Benefit-risk considerations in metamizole treatment. Rational recommendations for indications and contra-indications according to current knowledge Fortschritte der Medizin 100(14): 615-618
Daly, R. 2011: Cost-benefit ratio. GOP isn't alone in pushing for Medicare changes Modern Healthcare 41(21): 8-9
Duff, P.; Dolphin, C. 2007: Cost-benefit analysis of assistive technology to support independence for people with dementia – Part 2: Results from employing the ENABLE cost-benefit model in practice Technology and Disability 19(2-3): 79-90
Cárdenas Ayala, V.M.; Ruiz Matus, C.; Cabrera Coello, L.; Montesano Castellanos, R.; Garrido Lozada, M.T.; Olvera Castillo, R.; Díaz Ortega, J.L. 1989: Estimate of the cost/benefit ratio of measles vaccination Salud Publica de Mexico 31(6): 735-744
Garavaglia, C. 1979: Cost/benefit ratio in the radiologic prevention of occupational pneumoconiosis La Radiologia Medica 65(11): 840-842
Reynier-Rebuffel, A.M. 1970: Characteristic current-tension of excitable artificial lipid membranes. its variation in relation to current establishment time Journal de Physiologie 62(Suppl 3): 434-435
Di Mauro, S.; Salibra, M.; Belnome, N.A.; Barbera, S.; Turrisi, M.; Di Mauro, F.; Nucera, M.L. 2001: Use of monofilament prosthesis in inguinal hernia treatment: cost-benefit ratio Minerva Chirurgica 56(3): 283-286